









Markets
/
Stocks
/
nasdaq-drts
/

Alpha Tau Medical Ltd

DRTS



View Detailed Chart

5.070USD

-0.030-0.59%

Market hours （ET）Quotes delayed by 15 min

432.29MMarket Cap

LossP/E TTM



Alpha Tau Medical Ltd

5.070

-0.030-0.59%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Intraday

30m

Today

-0.59%

5 Days

-0.78%

1 Month

+32.72%

6 Months

+74.83%

Year to Date

+63.55%

1 Year

+63.55%

View Detailed Chart

TradingKey Stock Score of Alpha Tau Medical Ltd

Currency: USD Updated: 2025-10-27

Key Insights

Its valuation is considered undervalued, Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at max_target_price.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Alpha Tau Medical Ltd's Score

Industry at a Glance

Industry Ranking

154 / 204

Overall Ranking

428 / 4682

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Analyst Rating

Based on 4 analysts

Strong Buy

Current Rating

8.500

Target Price

+118.51%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Alpha Tau Medical Ltd Highlights

StrengthsRisks

Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.

Undervalued

The company’s latest PE is -8.61, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 1.93M shares, increasing 4.40% quarter-over-quarter.

Held by James Simons

Star Investor James Simons holds 29.40K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.42.